BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38507172)

  • 1. LINC00963 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma by Interacting with miR-10a to Upregulate SKA1 Expression.
    Hu D; Ma A; Lu H; Gao Z; Yu Y; Fan J; Liu S; Wang Y; Zhang M
    Appl Biochem Biotechnol; 2024 Mar; ():. PubMed ID: 38507172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2.
    Zhang Z; Xiong R; Li C; Xu M; Guo M
    Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):826-833. PubMed ID: 31287493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00963 predicts poor prognosis and promotes esophageal cancer cells invasion via targeting miR-214-5p/RAB14 axis.
    Liu HF; Zhen Q; Fan YK
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):164-173. PubMed ID: 31957829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
    Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
    J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-10a-5p inhibits cell metastasis in hepatocellular carcinoma via targeting SKA1.
    Shen D; Zhao HY; Gu AD; Wu YW; Weng YH; Li SJ; Song JY; Gu XF; Qiu J; Zhao W
    Kaohsiung J Med Sci; 2021 Sep; 37(9):784-794. PubMed ID: 34002462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00261 Suppresses Cisplatin Resistance of Esophageal Squamous Cell Carcinoma Through miR-545-3p/MT1M Axis.
    Wang L; Wang X; Yan P; Liu Y; Jiang X
    Front Cell Dev Biol; 2021; 9():687788. PubMed ID: 34336838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of circPSMC3 sensitizes gefitinib-resistant esophageal squamous cell carcinoma cells to gefitinib by regulating miR-10a-5p/PTEN axis.
    Zhu H; Du F; Cao C
    Cell Biol Int; 2021 Jan; 45(1):107-116. PubMed ID: 32997362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
    Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
    Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
    Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.
    Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L
    Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-suppressive microRNA-10a inhibits cell proliferation and metastasis by targeting Tiam1 in esophageal squamous cell carcinoma.
    Liu Y; Wang X; Jiang X; Yan P; Zhan L; Zhu H; Wang T; Wen J
    J Cell Biochem; 2019 May; 120(5):7845-7857. PubMed ID: 30426564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway.
    Zheng TL; Li DP; He ZF; Zhao S
    Cancer Cell Int; 2019; 19():250. PubMed ID: 31582906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETV5 overexpression promotes progression of esophageal squamous cell carcinoma by upregulating SKA1 and TRPV2.
    Sun MC; Fang K; Li ZX; Chu Y; Xu AP; Zhao ZY; Leng ZY; Zhang YW; Zhang ZH; Zhang L; Chen T; Xu MD
    Int J Med Sci; 2022; 19(6):1072-1081. PubMed ID: 35813298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
    Wang J; Jia J; Zhou L
    Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
    Arai T; Okato A; Kojima S; Idichi T; Koshizuka K; Kurozumi A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2017 Oct; 108(10):2088-2101. PubMed ID: 28746769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.
    Zhao L; Li QQ; Zhang R; Xi M; Liao YJ; Qian D; He LR; Zeng YX; Xie D; Liu MZ
    Tumour Biol; 2012 Aug; 33(4):1115-23. PubMed ID: 22389159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of METTL14-mediated m
    Gong S; Wang S; Shao M
    J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.